Flooding in Louisiana has caused tens of millions of dollars in property damage and untold personal misery. But public response has been slow. Join us to talk about why we open our hearts and wallets for some disasters and not others.
Food scares and drug scandals have raised serious concerns over the F.D.A.’s ability to regulate effectively. A look at the resources and direction at the Food and Drug Administration, and why some are hoping for significant changes under the next administration.
- Rep. Rosa DeLauro U.S. Congresswoman, representing Connecticut's 3rd district; chairwoman of the Agriculture-FDA Appropriations Subcommittee
- William Hubbard former associate commissioner for the Food and Drug Administration; spokesperson for the Alliance for a Stronger FDA
- Alan Goldhammer, PhD associate vice president for regulatory affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA)
- Dr. Sidney Wolfe director of the Health Research Group at Public Citizen; editor of WorstPills.org
- Gardiner Harris science reporter for "The New York Times"
Most Recent Shows
Last week, the Zika virus continued to spread through parts of Miami Beach. The National Institutes of Health warns that Texas and Louisiana could be next. The growing Zika threat, tough choices for pregnant women and the search for a vaccine.
Dr. Nicholas Dodman talks animal psychology. He says animal emotions and thoughts can be treated more like our own. Why he believes we can improve the mental health of our pets, and what animals teach us about human medicine.
The U.S. will phase out the use of private prisons to incarcerate federal inmates. New findings by the Department of Justice conclude that private facilities are less safe and offer few cost advantages. We discuss implications of the phase-out and what it could mean for America's prison system.